ANI Pharmaceuticals | ANIP - Ebitda

Stock Price
78.64
Daily Change
0.58 0.74%
Monthly
6.17%
Yearly
12.63%
Q2 Forecast
76.96

ANI Pharmaceuticals reported $65.36M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
AbbVie USD 3.52B 828M Sep/2025
ANI Pharmaceuticals USD 65.36M 5.76M Dec/2025
Aurora Cannabis CAD 18.48M 3.11M Dec/2025
Canopy Growth CAD -2.87M 19.49M Dec/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
Heron Therapeutics USD -3.88M 5.63M Sep/2024
Hikma Pharmaceutical USD 369M 84M Dec/2024
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Nektar Therapeutics USD -31.81M 70K Sep/2023
Novartis USD 5.84B 235M Sep/2025
Omeros USD -47.96M 7.39M Sep/2023
Perrigo USD 258.8M 37.3M Sep/2025
Sun Pharmaceuticals INR 49.48B 8.52B Dec/2025
Teva Pharmaceutical Industries USD 1.64B 243M Dec/2025